Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Body size and risk of differen...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Body size and risk of differentiated thyroid carcinomas: Findings from the EPIC study

Body size and risk of differentiated thyroid carcinomas: Findings from the EPIC study

Show other versions (1)
Bibliographic Details
Main Authors: Rinaldi, S, Lise, M, Clavel-Chapelon, F, Boutron-Ruault, M, Guillas, G, Overvad, K, Tjonneland, A, Halkjaer, J, Lukanova, A, Kaaks, R, Bergmann, M, Boeing, H, Trichopoulou, A, Zylis, D, Valanou, E, Palli, D, Agnoli, C, Tumino, R, Polidoro, S, Mattiello, A, Bueno-de-Mesquita, H, Peeters, P, Weiderpass, E, Lund, E, Skeie, G
Format: Journal article
Published: 2012
  • Holdings
  • Description
  • Other Versions (1)
  • Similar Items
  • Staff View

Similar Items

  • Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study.
    by: Rinaldi, S, et al.
    Published: (2012)
  • Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study.
    by: Rinaldi, S, et al.
    Published: (2014)
  • Plasma cotinine levels and pancreatic cancer in the EPIC cohort study
    by: Leenders, M, et al.
    Published: (2011)
  • Plasma cotinine levels and pancreatic cancer in the EPIC cohort study.
    by: Leenders, M, et al.
    Published: (2012)
  • The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC Cohort.
    by: Grote, V, et al.
    Published: (2012)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs